Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
FDAnews
FDAnews
Activities:
Media
Training & Education
Regulatory
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
FDA approves Xadago for Parkinson’s patients
Xadago (safinamide) is first NCE approved in the USA for PD patients with motor fluctuations in a decade
Regulatory
New FDA binding guidelines force industry switch to digital
From December 2017, the FDA will require all NGA licence applications to be submitted electronically – part of a push towards a digital data pharma industry
Regulatory
FDA issues guidance to prevent listeria
New US guidance from the FDA will help keep RTE foods free from bacterium <em>Listeria monocytogenes</em>
Pharmaceutical
FDA research to help speed development of Zika virus vaccines and therapeutics
A new mouse model developed by scientists at the U.S. Food and Drug Administration may help in exploring the potential activity of Zika virus vaccines and therapeutics.
Subscribe now